Lion (TSE:4912) Could Be 15% Undervalued If Its Asia Growth Story Holds

Lion (TSE:4912) shares recently drew attention after a modest daily gain alongside mixed short term returns, with the stock up 1.2% over the past 3 months but down 3% over the past month.

See our latest analysis for Lion.

At the current share price of ¥1,659.5, Lion’s recent 7 day and 30 day share price returns have softened, yet its 1 year total shareholder return of 15.35% and 3 year total shareholder return of 30.99% point to a steadier longer term picture.

If you are comparing Lion’s profile with other opportunities, this could be a good moment to widen your search and review 10 top founder-led companies

The recent pullback in Lion, despite solid multi year shareholder returns, raises a simple tension: are traders cooling on the stock, or does the current price still line up with the underlying business value that investors are paying for?

Most Popular Narrative: 15.4% Undervalued

Compared with Lion’s last close at ¥1,659.5, the most followed narrative puts fair value at ¥1,960.83, creating a clear gap for investors to assess.

The company is expanding its presence in Southeast Asia, South Asia, and China, with strategies to capture untapped markets and shift to high-value-added products. The focus on emerging and populous markets is likely to drive significant revenue growth.

Read the complete narrative.

Want to see what sits behind that growth story? The narrative leans on steady top line expansion, resilient margins and a higher earnings multiple than today. The exact mix of assumptions may surprise you.

Using a 4.912% discount rate, the narrative ties together expected revenue growth, profit margins and a future P/E multiple to arrive at a fair value of ¥1,960.83 for Lion. Compared with the current share price, that implies Lion is trading at a discount to those consensus assumptions, leaving readers to decide whether the growth, margin and valuation profile feels achievable.

Result: Fair Value of ¥1,960.83 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Lion’s story could change quickly if overseas markets such as China prove tougher than analysts expect, or if the product shift toward Oral Health Care hits execution snags.

Find out about the key risks to this Lion narrative.

Next Steps

Does the mixed sentiment around Lion leave you unsure which way to lean? Take a closer look at the underlying data, weigh both the concerns and the potential upsides, and then check the 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Lion?

If Lion has your attention, do not stop there. Broader ideas can help you stress test your thinking and avoid missing opportunities sitting in plain sight.

• Explore potential mispricings by scanning companies that currently look undervalued using the 16 high quality undervalued stocks.
• Support an income-focused approach by reviewing the 43 dividend fortresses before the next round of payouts.
• Consider managing downside risk by shortlisting resilient companies through the 53 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com